99% Savings - Buy Just @1 Rs X
Olmesafe 40 Tablet is a prescription medicine that is available as a Tablet. Primarily, it is used for the treatment of High BP. Olmesafe 40 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Olmesafe 40 Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.
Common side effects of Olmesafe 40 Tablet include Upper respiratory tract infection. Some other side effects of Olmesafe 40 Tablet have been listed ahead. Such side effects of Olmesafe 40 Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Furthermore, you should know that effect of Olmesafe 40 Tablet is Severe for pregnant women and Mild for women who are breastfeeding. Further, the section on Olmesafe 40 Tablet related warnings talks about Olmesafe 40 Tablet's effects on the liver, heart and kidney.
Olmesafe 40 Tablet is contraindicated in people with pre-existing medical conditions like Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension) as it can result in adverse effects. Some other conditions that can be affected by Olmesafe 40 Tablet are listed in the contraindications section below.
Drug reaction of Olmesafe 40 Tablet with other medicines has been reported. Refer to the list below for further details.
You should also be aware that Olmesafe 40 Tablet is not safe while driving, and is not addiction.
Olmesafe 40 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Olmesafe 40 Tablet safe for pregnant women?
Olmesafe should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olmesafe 40 Tablet safe during breastfeeding?
Olmesafe may have very limited harmful effects for breastfeeding women.
What is the effect of Olmesafe 40 Tablet on the Kidneys?
Olmesafe rarely affects the kidneys.
What is the effect of Olmesafe 40 Tablet on the Liver?
Very few cases of side effects of Olmesafe on the liver have been reported.
What is the effect of Olmesafe 40 Tablet on the Heart?
Side effects of Olmesafe rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Olmesafe 40 Tablet unless your doctor advises you to do so -
Is this Olmesafe 40 Tablet habit forming or addictive?
No, there is no any evidence that Olmesafe 40 Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Olmesafe 40 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Olmesafe 40 Tablet is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
No, Olmesafe 40 Tablet is not used to treat mental disorders.
Interaction between Food and Olmesafe 40 Tablet
Eating certain foods may increase the time it takes Olmesafe 40 Tablet to have an effect. You should consult your doctor about it.
Interaction between Alcohol and Olmesafe 40 Tablet
Consuming Olmesafe 40 Tablet with alcohol can have many serious effects on your body.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173